The DOI matches its Crossref record; 583 of the 585 references it cites were found in a registry or an index.
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Open accessAbstract
The ESC Guidelines represent the views of the ESC and were produced after careful consideration of the scientific and medical knowledge and the evidence available at the time of their publication.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Healthy lifestyle choices can prevent or delay the onset of high BP and can reduce cardiovascular risk. 46”
From 2020 International Society of Hypertension Global Hypertension Practice Guidelines (2020) · cites this paper as [46]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“in fact, the classic calculators for estimating cardiovascular risk that only consider conventional risk factors, such as the Framingham risk score, could underestimate the risk in this particular population [8].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Traditional risk factors alone cannot fully explain the high impact of coronary events in effectively treated patients; in fact, the classic calculators for estimating cardiovascular risk that only consider conventional risk factors, such as the Framingham risk score, could underestimate the risk in this particular population [8].”
From Residual Cardiovascular Risk: Role of Remnants Cholesterol, Monocyte/HDL Ratio and Lipoprotein Ratios on Personalized Cardiovascular Prevention (2024) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Intolerance to statins is linked with an elevated risk of cardiovascular disease [3].”
From Safety outcomes of statin vs non-statin lipid-lowering interventions in patients with prior statin-associated muscle symptoms: A systematic review and meta-analysis (2025) · cites this paper as [3]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The higher discontinuation rate observed with statins may reflect challenges in patient adherence and could have implications for long-term cardiovascular risk prevention [3].”
From Safety outcomes of statin vs non-statin lipid-lowering interventions in patients with prior statin-associated muscle symptoms: A systematic review and meta-analysis (2025) · cites this paper as [3]
Experimental — accuracy not yet measured
In the citing paper
“The European Guidelines on CVD prevention in clinical practice (both the 2012 [9] and 2016 [10] versions) recommend the use of the SCORE system because it is based on large, representative European cohort data sets and because it is relatively straightforward to recalibrate for individual countries.”
From 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk (2019) · cites this paper as [10]
In the citing paper
“In conditions whose pathophysiology is better understood, such as cardiovascular disease and stroke, comprehensive targeted prevention strategies can be developed and disseminated.”
From Precision clinical trials: a framework for getting to precision medicine for neurobehavioural disorders (2021) · cites this paper as [7]
In the citing paper
“Based upon the many epidemiological and nutrition studies suggesting a positive association between red meat ingestion and CVD risks, [27][28][29][30][31][32][33] most dietary recommendations advise limiting red meat ingestion.26”
From Impact of chronic dietary red meat, white meat, or non-meat protein on trimethylamine N-oxide metabolism and renal excretion in healthy men and women (2019) · cites this paper as [26]
In the citing paper
“Findings from our review are consistent with European and American evidence based guidelines on prevention of cardiovascular disease that highlighted pre-eclampsia, gestational diabetes, and preterm birth as adverse pregnancy outcomes that potentially increase the risk of cardiovascular disease”
From Association between the reproductive health of young women and cardiovascular disease in later life: umbrella review (2020) · cites this paper as [131]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
4 retracted
RETRACTED: Primary Prevention of Cardiovascular Disease with a Mediterranean Diet
Estruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1200303 · Cited by 4,257
RetractedEstruch, R., Ros, E., Salas-Salvadó, J., Covas, M.-I., Corella, D., Arós, F., Gómez-Gracia, E., Ruiz-Gutiérrez, V., Fiol, M., Lapetra, J., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmc1806491 · Cited by 1,008
RetractedShaw, L. J., Bairey Merz, C. N., Azziz, R., Stanczyk, F. Z., Sopko, G., Braunstein, G. D., Kelsey, S. F., Kip, K. E., Cooper-DeHoff, R. M., Johnson, B. D., et al. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0425 · Cited by 427
RetractedSmoking cessation for the secondary prevention of coronary heart disease
Critchley, J., & Capewell, S. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003041.pub2 · Cited by 342
RetractedFriedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
A New Method for Measuring Daytime Sleepiness: The Epworth Sleepiness Scale
Johns, M. W. (1991) · Sleep · doi:10.1093/sleep/14.6.540 · Cited by 17,364
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Zinman, B., Wanner, C., Lachin, J. M., Fitchett, D., Bluhmki, E., Hantel, S., Mattheus, M., Devins, T., Johansen, O. E., Woerle, H. J., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504720 · Cited by 12,315
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Lim, S. S., Vos, T., Flaxman, A. D., Danaei, G., Shibuya, K., Adair-Rohani, H., AlMazroa, M. A., Amann, M., Anderson, H. R., Andrews, K. G., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61766-8 · Cited by 11,805
Research works printed but not linked: 29
- A Dictionary of Epidemiology. 4th ed
- NICE Public Health Guidance 25. Prevention of Cardiovascular Disease
- World Health Organization, Global status report on non-communicable diseases 2010
- Nichols M, European Cardiovascular Disease Statistics, 2012 edition.
- World Health Organization, 2011, Scaling up action agains noncommunicable diseases: how much will it cost?
- American Heart Association, Heart-Health Screenings
- World Health Organisation, WHO Global Health Repository. Cardiovascular diseases, deaths per 100 000. Data by country.
- Fajardo, 1999, Is the pathology of radiation injury different in small vs large blood vessels?, Cardiovasc Radiat Med, 1, 108
- World Health Organization, 1999, Familial hypercholesterolemia—report of a second WHO consultation.
- Lozano Sanchez, 2013, [Cardiovascular risk of immigrants living in Spain according to origin years of stay], Aten Primaria, 45, 92
- Albus, 2014, [Psychocardiology: clinically relevant recommendations regarding selected cardiovascular diseases], Dtsch Med Wochenschr, 139, 596
- Campbell F, 2012, National Institute for Health and Clinical Excellence (NICE) public health intervention guidance physical activity: BA for adults in primary care. Review of effectiveness evidence
- Physical Activity Guidelines Advisory Committee, 2008, Physical Activity Guidelines Advisory Committee Report, 2008
- Department of Health, Physical Activity, Health Improvement and Protection, Stay Active: A report on physical activity for health from the four home countries' Chief Medical Officers
- West, Key performance indicators: findings from the Smoking Toolkit Study
- Centers for Disease Control and Prevention, How Tobacco Smoke Causes Disease: The Biology and Behavioural Basis for Smoking-attributable Disease 2010. A Report of the Surgeon General
- European Heart Network, 2011, Diet, Physical Activity and Cardiovascular Disease Prevention in Europe
- World Health Organization, 2015, Guideline: Sugars Intake for Adults and Children
- Emerging Risk Factors Collaboration, 2009, Di Angelantonio E, Sarwar N, Perry P, Kaptoge S, Ray KK, Thompson A, Wood AM, Lewington S, Sattar N, Packard CJ, Collins R, Thompson SG, Danesh J. Major lipids, apolipoproteins, and risk of vascular disease, JAMA, 302, 1993
- Voight, 2012, Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study, Lancet, 380, 572, 10.1016/S0140-6736(12)60312-2 · DOI · Paper page
- Liu, 2000, Anticoagulants for preventing recurrence following ischaemic stroke or transient ischaemic attack, Cochrane Database Syst Rev, 2, CD000248
- ASCEND. A Study of Cardiovascular Events in Diabetes
- Aspirin to Reduce Risk of Initial Vascular Events (ARRIVE) Trial
- National Institute for Health and Care Excellence, 2010, Prevention of cardiovascular disease at the population level.
- 2013, Exercise prescription for health—the green prescription
- American College of Sports Medicine, 2014, ACSM's guidelines for exercise testing and prescription. 9th ed
- Gallefoss, 2012, Snus under svangerskap er ikke ufarlig, Tidsskrift for Den norske legeforening, 132, 932
- World Health Organization, Global status report on alcohol and health.
- National Institute for Health and Care Excellence, Alcohol-use disorders: preventing the development of hazardous and harmful drinking
Cited by
Sorted by citations
Items 201–300 of 1,031
Rempenault, C., Combe, B. G., Barnetche, T., Gaujoux-Viala, C., Lukas, C., Morel, J., & Hua, C. (2017) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211836 · Cited by 221
Näslund, U., Ng, N., Lundgren, A., Fhärm, E., Grönlund, C., Johansson, H., Lindahl, B., Lindahl, B., Lindvall, K., Nilsson, S. K., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)32818-6 · Cited by 220
Red meat consumption, cardiovascular diseases, and diabetes: a systematic review and meta-analysis
Shi, W., Huang, X., Schooling, C. M., & Zhao, J. V. (2023) · European Heart Journal · doi:10.1093/eurheartj/ehad336 · Cited by 245
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis
Patrono, C., Morais, J., Baigent, C., Collet, J., Fitzgerald, D. J., Halvorsen, S., Rocca, B., Siegbahn, A., Storey, R. F., & Vilahur, G. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.08.037 · Cited by 233
A Renewed Focus on the Association Between Thyroid Hormones and Lipid Metabolism
Duntas, L. H., & Brenta, G. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00511 · Cited by 230
Comorbidities in clinical practice. Algorithms for diagnostics and treatment
Гегамович, О. Р., Simanenkov, V. I., Бакулин, И. Г., Бакулина, Н. В., Барбараш, О. Л., Boytsov, S. A., Афанасьевна, Б. С., Garganeeva, N. P., Doshchitsin, V. L., Karateev, A. E., et al. (2019) · CARDIOVASCULAR THERAPY AND PREVENTION · doi:10.15829/1728-8800-2019-1-5-66 · Cited by 253
Piepoli, M. F., Abreu, A., Albus, C., Ambrosetti, M., Brotons, C., Catapano, A. L., Corrà, U., Cosyns, B., Deaton, C., Graham, I. M., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319893035 · Cited by 226
Self-citationKuntić, M., Oelze, M. W., Steven, S., Kröller‐Schön, S., Stamm, P., Kalinovic, S., Frenis, K., Vujačić-Mirski, K., Jiménez, M. T. B., Kvandová, M., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz772 · Cited by 217
Lauridsen, B. K., Stender, S., Kristensen, T. S., Kofoed, K. F., Køber, L., Nordestgaard, B. G., & Tybjærg‐Hansen, A. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx662 · Cited by 222
Aspirin-free strategies in cardiovascular disease and cardioembolic stroke prevention
Capodanno, D., Mehran, R., Valgimigli, M., Baber, U., Windecker, S., Vranckx, P., Dangas, G., Rollini, F., Kimura, T., Collet, J., et al. (2018) · Nature Reviews Cardiology · doi:10.1038/s41569-018-0049-1 · Cited by 220
Self-citationHanssen, H., Boardman, H., Deiseroth, A., Moholdt, T. T., Simonenko, M., Kränkel, N., Niebauer, J., Tiberi, M., Abreu, A., Solberg, E. E., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaa141 · Cited by 236
Self-citationSteffen, A., Nübel, J., Jacobi, F., Bätzing, J., & Holstiege, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-020-02546-8 · Cited by 212
Depression and cardiovascular disease: The deep blue sea of women's heart
Bucciarelli, V., Caterino, A. L., Bianco, F., Caputi, C. G., Salerni, S., Sciomer, S., Maffei, S., & Gallina, S. (2019) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2019.05.001 · Cited by 209
Guedeney, P., Giustino, G., Sorrentino, S., Claessen, B. E., Camaj, A., Kalkman, D. N., Vogel, B., Sartori, S., De Rosa, S., Baber, U., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehz430 · Cited by 208
Patel, A. P., Wang, M., Kartoun, U., Ng, K., & Khera, A. V. (2021) · Circulation · doi:10.1161/circulationaha.120.052430 · Cited by 215
Ikonomidis, I., Pavlidis, G., Thymis, J., Birba, D., Kalogeris, A., Kousathana, F., Kountouri, A., Balampanis, K., Parissis, J., Andreadou, I., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015716 · Cited by 199
Chaumont, M., Becker, B. D., Zaher, W., Culié, A., Deprez, G., Mélot, C., Reyé, F., Antwerpen, P. V., Delporte, C., Debbas, N., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-28723-0 · Cited by 203
Vernon, S. T., Coffey, S., D'Souza, M. I., Chow, C. K., Kilian, J. G., Hyun, K. K., Shaw, J. A., Adams, M., Roberts‐Thomson, P., Brieger, D. B., et al. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.013296 · Cited by 203
Hypertension as a risk factor for atherosclerosis: Cardiovascular risk assessment
Poznyak, A. V., Sadykhov, N. K., Kartuesov, A. G., Borisov, E. E., Melnichenko, A. А., Grechko, A. V., & Orekhov, A. N. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.959285 · Cited by 229
Pedret, A., Valls, R. M., Calderón-Pérez, L., Llauradó, E., Companys, J., Pla‐Pagà, L., Moragas, A., Martín‐Luján, F., Ortega, Y., Giralt, M., et al. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0220-0 · Cited by 210
Landmesser, U., Chapman, M. J., Stock, J. K., Amarenco, P., Belch, J. J. F., Borén, J., Farnier, M., Ference, B. A., Gielen, S., Graham, I., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehx549 · Cited by 200
Self-citationMozos, I. M., Stoian, D. L., Caraba, A., Malainer, C., Horbańczuk, J. O., & Atanasov, A. G. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00521 · Cited by 200
Schulze, M. B., Minihane, A. M., Saleh, R. N. M., & Risérus, U. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30148-0 · Cited by 200
Klok, F. A., Ageno, W., Ay, C., Bäck, M., Barco, S., Bertoletti, L., Becattini, C., Carlsen, J., Delcroix, M., van Es, N., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab816 · Cited by 198
The fourth industrial revolution in the food industry—part II: Emerging food trends
Hassoun, A., Bekhit, A. E. A., Jambrak, A. ., Regenstein, J. M., Chemat, F., Morton, J. D., Guðjónsdóttir, M., Carpena, M., Prieto, M. A., Varela, P., et al. (2022) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2022.2106472 · Cited by 211
Phytosterols, Cholesterol Control, and Cardiovascular Disease
Poli, A., Marangoni, F., Corsini, A., Manzato, E., Marrocco, W., Martini, D., Medea, G., & Visioli, F. (2021) · Nutrients · doi:10.3390/nu13082810 · Cited by 201
Gorostidi, M., Sánchez-Martínez, M., Ruilope, L. M., Graciani, A., de la Cruz, J. J., Santamaría, R., y Pino, M. D. D. P., Guallar‐Castillón, P., de Álvaro, F., Rodríguez‐Artalejo, F., et al. (2018) · Nefrología · doi:10.1016/j.nefro.2018.04.004 · Cited by 224
Kim, S. H., Cho, Y. K., Kim, Y., Jung, C. H., Lee, W. J., Park, J., Huh, J. H., Kang, J. G., Lee, S. J., & Ihm, S. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01522-8 · Cited by 195
Werner, C. M., Hecksteden, A., Morsch, A., Zundler, J., Wegmann, M., Kratzsch, J., Thiery, J., Hohl, M., Bittenbring, J. T., Neumann, F., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehy585 · Cited by 194
Vulnerable plaques and patients: state-of-the-art
Tomaniak, M., Katagiri, Y., Modolo, R., de Silva, R., Khamis, R. Y., Bourantas, C. V., Torii, R., Wentzel, J. J., Gijsen, F. J. H., van Soest, G., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa227 · Cited by 197
Platelet to Lymphocyte Ratio in Cardiovascular Diseases: A Systematic Review
Kurtul, A., & Örnek, E. (2019) · Angiology · doi:10.1177/0003319719845186 · Cited by 196
Buscot, M., Thomson, R. J., Juonala, M., Sabin, M. A., Burgner, D. P., Lehtimäki, T. J., Hutri‐Kähönen, N., Viikari, J. S. A., Raitakari, O. T., & Magnussen, C. G. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy161 · Cited by 190
Marchisello, S., Pino, A. D., Scicali, R., Urbano, F., Piro, S., Purrello, F., & Rabuazzo, A. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081948 · Cited by 202
Hansen, D., Dendale, P., Coninx, K., Vanhees, L., Piepoli, M. F., Niebauer, J., Cornelissen, V., Pedretti, R. F. E., Geurts, E., Rovelo, G., et al. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317702042 · Cited by 189
Self-citationNorris, C. M., Yip, C. Y. Y., Nerenberg, K. A., Clavel, M.-A. A., Pacheco, C., Foulds, H. J. A., Hardy, M., Gonsalves, C. A., Jaffer, S., Parry, M. J. E., et al. (2020) · Journal of the American Heart Association · doi:10.1161/jaha.119.015634 · Cited by 202
Ruuth, M., Nguyen, S. D., Vihervaara, T., Hilvo, M., Laajala, T. D., Kondadi, P. K., Gisterå, A., Lähteenmäki, H., Kittilä, T., Huusko, J., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy319 · Cited by 180
Proietti, M., Romiti, G. F., Olshansky, B., Lane, D. A., & Lip, G. Y. H. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.06.012 · Cited by 188
Self-citationAbreu, A., Frederix, I., Dendale, P., Janssen, A., Doherty, P., Piepoli, M. F., Völler, H., Davos, C. H., Reviewers:, T. S. P. A. R. S. O. E., & Ambrosetti, M. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320924912 · Cited by 204
Self-citationFragki, S., Dirven, H. A. A. M., Fletcher, T., Grasl‐Kraupp, B., Gützkow, K. B., Hoogenboom, L. A. P., Kersten, S., Lindeman, B., Louisse, J., Peijnenburg, A., et al. (2021) · Critical Reviews in Toxicology · doi:10.1080/10408444.2021.1888073 · Cited by 196
Phytosterols in the Treatment of Hypercholesterolemia and Prevention of Cardiovascular Diseases
Cabral, C. E. L., & Klein, M. R. S. T. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170158 · Cited by 190
Dietary recommendations for prevention of atherosclerosis
Riccardi, G., Giosuè, A., Calabrese, I., & Vaccaro, O. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab173 · Cited by 194
Imaging residual inflammatory cardiovascular risk
Antoniades, C. A., Antonopoulos, A. S., & Deanfield, J. E. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz474 · Cited by 185
Sakai, C., Ishida, M., Ohba, H., Yamashita, H., Uchida, H., Yoshizumi, M., & Ishida, T. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187934 · Cited by 188
Terlouw, L. G., Moelker, A. D., Abrahamsen, J., Acosta, S., Bakker, O. J., Baumgärtner, I., Boyer, L., Corcos, O., van Dijk, L. J. D., Duran, M., et al. (2020) · United European Gastroenterology Journal · doi:10.1177/2050640620916681 · Cited by 190
Albus, C., Waller, C., Fritzsche, K., Gunold, H., Haass, M., Hamann, B., Kindermann, I., Köllner, V., Leithäuser, B., Marx, N., et al. (2019) · Clinical Research in Cardiology · doi:10.1007/s00392-019-01488-w · Cited by 178
Self-citationBenn, M., Nordestgaard, B. G., Frikke-Schmidt, R., & Tybjærg-Hansen, A. (2017) · BMJ · doi:10.1136/bmj.j1648 · Cited by 178
Grünig, E., Eichstaedt, C. A., Barberà, J. A., Benjamin, N., Blanco, I., Bossone, E., Cittadini, A., Coghlan, G., Corris, P. A., D’Alto, M., et al. (2018) · European Respiratory Journal · doi:10.1183/13993003.00332-2018 · Cited by 190
Mahmoud, A. N., Gad, M. M., Elgendy, A. Y., Elgendy, I. Y., & Bavry, A. A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy813 · Cited by 178
Ogino, H., Iida, O., Akutsu, K., Chiba, Y., Hayashi, H., Ishibashi‐Ueda, H., Kaji, S., Kato, M., Komori, K., Matsuda, H., et al. (2023) · Circulation Journal · doi:10.1253/circj.cj-22-0794 · Cited by 182
Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy
Vinci, P., Panizon, E., Tosoni, L. M., Cerrato, C., Pellicori, F., Mearelli, F., Biasinutto, C., Fiotti, N., Girolamo, F. G. D., & Biolo, G. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111687 · Cited by 188
The rise and fall of aspirin in the primary prevention of cardiovascular disease
Raber, I., McCarthy, C. P., Vaduganathan, M., Bhatt, D. L., Wood, D. A., Cleland, J. G. F., Blumenthal, R. S., & McEvoy, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(19)30541-0 · Cited by 175
Kotseva, K., Backer, G. D., Bacquer, D. D., Rydén, L., Hoes, A. W., Grobbee, D. E., Maggioni, A. P., Marques-Vidal, P. M., Jennings, C. S., Abreu, A., et al. (2020) · European Journal of Preventive Cardiology · doi:10.1177/2047487320908698 · Cited by 184
Self-citationRisk scoring for the primary prevention of cardiovascular disease
Karmali, K. N., Persell, S. D., Perel, P., Lloyd‐Jones, D. M., Berendsen, M. A., & Huffman, M. D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006887.pub4 · Cited by 182
Botts, S. R., Fish, J. E., & Howe, K. L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.787541 · Cited by 181
Systematic comparison of family history and polygenic risk across 24 common diseases
Mars, N., Lindbohm, J. V., Parolo, P. D. B., Widén, E., Kaprio, J. A., Palotie, A. V., FinnGen, & Ripatti, S. (2022) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2022.10.009 · Cited by 176
Cardiovascular Disease and Frailty: What Are the Mechanistic Links?
Stewart, R. (2018) · Clinical Chemistry · doi:10.1373/clinchem.2018.287318 · Cited by 171
The Task Force for the management of COVID-19 of the European Society of Cardiology, Baigent, C., Windecker, S., Andreini, D., Arbelo, E., Barbato, E., Bartorelli, A. L., Baumbach, A., Behr, E. R., Berti, S. L., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab697 · Cited by 177
Self-citationTrends in Noncardiovascular Comorbidities Among Patients Hospitalized for Heart Failure
Sharma, A., Zhao, X., Hammill, B. G., Hernandez, A. F., Fonarow, G. C., Felker, G. M., Yancy, C. W., Heidenreich, P. A., Ezekowitz, J. A., & DeVore, A. D. (2018) · Circulation Heart Failure · doi:10.1161/circheartfailure.117.004646 · Cited by 169
Zhou, X., Cai, J., Targher, G., Byrne, C. D., Shapiro, M. D., Sung, K., Somers, V. K., Chahal, C. A. A., George, J., Chen, L., et al. (2022) · Cardiovascular Diabetology · doi:10.1186/s12933-022-01697-0 · Cited by 174
Tada, H., Kawashiri, M., Nohara, A., Inazu, A., Mabuchi, H., & Yamagishi, M. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx004 · Cited by 167
Giral, P., Neumann, A., Weill, A., & Coste, J. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz458 · Cited by 167
Kim, Y., Je, Y., & Giovannucci, E. L. (2020) · Clinical Nutrition · doi:10.1016/j.clnu.2020.07.007 · Cited by 175
Pennells, L. A. M., Kaptoge, S. K., Wood, A., Sweeting, M., Zhao, X., White, I. R., Burgess, S., Willeit, P., Bolton, T. R., Moons, K. G. M., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy653 · Cited by 164
Self-citationGaborit, B., Ancel, P., Abdullah, A., Maurice, F., Abdesselam, I., Calen, A., Soghomonian, A., Houssays, M., Varlet, I., Eisinger, M. J., et al. (2021) · Cardiovascular Diabetology · doi:10.1186/s12933-021-01237-2 · Cited by 174
Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer
Guirguis‐Blake, J., Evans, C. V., Perdue, L. A., Bean, S., & Senger, C. A. (2022) · JAMA · doi:10.1001/jama.2022.3337 · Cited by 169
Kivimäki, M., Pentti, J., Ferrie, J., Batty, G., Nyberg, S., Jokela, M., Virtanen, M., Alfredsson, L., Dragano, N., Fransson, E., et al. (2018) · The Lancet Diabetes and Endocrinology · doi:10.1016/s2213-8587(18)30140-2 · Cited by 136
Assessment of Cardiovascular Disease Risk
Goldsborough, E. F., Osuji, N., & Blaha, M. J. (2022) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2022.02.005 · Cited by 169
Diretriz Brasileira de Reabilitação Cardiovascular – 2020
de Carvalho, T., Milani, M., Ferraz, A. S., da Silveira, A. D., Herdy, A. H., Hossri, C. A. C., Silva, C. G. D. S. E., de Araújo, C. G. S., Rocco, E. A., Teixeira, J. A. C., et al. (2020) · Arquivos Brasileiros de Cardiologia · doi:10.36660/abc.20200407 · Cited by 206
Landmesser, U., Chapman, M. J., Farnier, M., Gencer, B., Gielen, S., Hovingh, G. K., Lüscher, T. F., Sinning, D., Tokgözoğlu, L. S., Wiklund, O., et al. (2016) · European Heart Journal · doi:10.1093/eurheartj/ehw480 · Cited by 164
Self-citationDorje, T., Zhao, G., Tso, K., Wang, J., Chen, Y., Tsokey, L., Tan, B.-K., Scheer, A., Jacques, A., Li, Z., et al. (2019) · The Lancet Digital Health · doi:10.1016/s2589-7500(19)30151-7 · Cited by 163
Primary Prevention With Statins in the Elderly
Mortensen, M. B., & Falk, E. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.10.080 · Cited by 164
Sumaya, W., Wallentin, L. C., James, S. K., Siegbahn, A. G., Gabrysch, K., Bertilsson, M., Himmelmänn, A., Ajjan, R., & Storey, R. F. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy013 · Cited by 160
Improving prevention strategies for cardiometabolic disease
Sattar, N. A., Gill, J. M. R., & Alazawi, W. (2020) · Nature Medicine · doi:10.1038/s41591-020-0786-7 · Cited by 174
Self-citationProgression of Early Subclinical Atherosclerosis (PESA) Study
Ibáñez, B., Fernández‐Ortíz, A., Fernández‐Friera, L., García‐Lunar, I., Andrés, V., & Fuster, V. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.05.011 · Cited by 171
Interactions between erectile dysfunction, cardiovascular disease and cardiovascular drugs
Terentes-Printzios, D. G., Ioakeimidis, N., Rokkas, K., & Vlachopoulos, C. V. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00593-6 · Cited by 172
Guideline recommendations and the positioning of newer drugs in type 2 diabetes care
Marx, N., Davies, M. J., Grant, P. J., Mathieu, C., Petrie, J. R., Cosentino, F., & Buse, J. B. (2020) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30343-0 · Cited by 160
Kabisch, N., Püffel, C., Masztalerz, O., Hemmerling, J., & Kraemer, R. (2020) · Landscape and Urban Planning · doi:10.1016/j.landurbplan.2020.103998 · Cited by 161
Chen, K., Breitner, S., Wolf, K., Hampel, R., Meisinger, C., Heier, M., von Scheidt, W., Kuch, B., Peters, A., Schneider, A. E., et al. (2019) · European Heart Journal · doi:10.1093/eurheartj/ehz116 · Cited by 156
Role of aspirin in primary prevention of cardiovascular disease
Patrono, C., & Baigent, C. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0225-y · Cited by 163
Subclinical thyroid dysfunction and cardiovascular diseases: 2016 update
Floriani, C., Gencer, B., Collet, T., & Rodondi, N. (2017) · European Heart Journal · doi:10.1093/eurheartj/ehx050 · Cited by 154
Risk Factor Management in Atrial Fibrillation
Brandes, A., Smit, M. D., Nguyen, B. O., Rienstra, M., & Gelder, I. C. V. (2018) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2018.18.2 · Cited by 163
Chinese Guidelines for the Prevention and Treatment of Hypertension (2024 revision)
Wang, J. (2025) · 老年心脏病学杂志：英文版 · doi:10.26599/1671-5411.2025.01.008 · Cited by 170
Aspirin for Primary Cardiovascular Risk Prevention and Beyond in Diabetes Mellitus
Capodanno, D., & Angiolillo, D. J. (2016) · Circulation · doi:10.1161/circulationaha.116.023164 · Cited by 158
ESC 2019 guidelines for the diagnosis and management of chronic coronary syndromes
Saraste, A., & Knuuti, J. M. (2020) · Herz · doi:10.1007/s00059-020-04935-x · Cited by 155
Home-based versus centre-based cardiac rehabilitation
McDonagh, S. T. J., Dalal, H. M., Moore, S. F., Clark, C. E., Dean, S. G., Jolly, K. B., Cowie, A., Afzal, J., & Taylor, R. S. (2023) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007130.pub5 · Cited by 178
Kalkman, D. N., Aquino, M. B., Claessen, B. E. P. M., Baber, U., Guedeney, P., Sorrentino, S., Vogel, B., de Winter, R. J., Sweeny, J. M., Kovacic, J. C., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy633 · Cited by 160
Olivera, P. A., Zuily, S., Kotze, P. G., Regnault, V., Awadhi, S. A., Bossuyt, P. J., Gearry, R. B., Ghosh, S. K., Kobayashi, T., Lacolley, P. J., et al. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00492-8 · Cited by 154
Watts, G. F., Chan, D. C., Somaratne, R. M., Wasserman, S. M., Scott, R. C., Marcovina, S. M., & Barrett, P. H. R. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy122 · Cited by 155
Primary prevention of ischaemic heart disease: populations, individuals, and health professionals
Gupta, R., & Wood, D. A. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31893-8 · Cited by 159
Cenko, E., Badimón, L., Bugiardini, R., Claeys, M. J., Luca, G. D., de Wit, C., Dérumeaux, G., Dorobanţu, M., Duncker, D. J., Eringa, E. C., et al. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab298 · Cited by 152
Markovitz, A. R., Stuart, J. J., Horn, J., Williams, P. L., Rimm, E. B., Missmer, S. A., Tanz, L. J., Haug, E. B., Fraser, A., Timpka, S., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy863 · Cited by 153
Cardiovascular Risk in Type 1 Diabetes Mellitus
Schofield, J. D., Ho, J. H., & Soran, H. (2019) · Diabetes Therapy · doi:10.1007/s13300-019-0612-8 · Cited by 164
Rosselló, X., Dorresteijn, J. A. N., Janssen, A., Lambrinou, E., Scherrenberg, M., Bonnefoy‐Cudraz, E., Cobain, M., Piepoli, M. F., Visseren, F. L. J., Dendale, P., et al. (2019) · European Journal of Preventive Cardiology · doi:10.1177/2047487319846715 · Cited by 162
Self-citationOmega 3-metabolism, absorption, bioavailability and health benefits–A review
Punia, S., Sandhu, K. S., Siroha, A. K., & Dhull, S. B. (2019) · PharmaNutrition · doi:10.1016/j.phanu.2019.100162 · Cited by 150
Galicia-García, U., Jebari‐Benslaiman, S., Larrea, A., Uribe, K. B., Siddiqi, H. F., Ostolaza, H., Benito‐Vicente, A., & Martín, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21134725 · Cited by 165
Poly-ADP-ribosylation in health and disease
Bonicalzi, M.-È., Haince, J.-F., Droit, A., & Poirier, G. G. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4505-1 · Cited by 157
Arnold, S. V., Inzucchi, S. E., Tang, F., McGuire, D. K., Mehta, S. N., Maddox, T. M., Goyal, A., Sperling, L. S., Einhorn, D., Wong, N. D., et al. (2017) · European Journal of Preventive Cardiology · doi:10.1177/2047487317729252 · Cited by 144
Forbes, C. A., Deshpande, S., Sorio-Vilela, F., Kutikova, L., Duffy, S., Gouni-Berthold, I., & Hagström, E. (2018) · Current Medical Research and Opinion · doi:10.1080/03007995.2018.1477747 · Cited by 149
Moore, A., & Bell, M. (2022) · Clinical Medicine Insights Cardiology · doi:10.1177/11795468221133611 · Cited by 158
Impact of cardiac rehabilitation and exercise training programs in coronary heart disease
Kachur, S. M., Chongthammakun, V., Lavie, C. J., Schutter, A. D., Arena, R. A., Milani, R. V., & Franklin, B. A. (2017) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2017.07.002 · Cited by 159
Metadata
- Authors
- Piepoli, M. F., Hoes, A. W., Agewall, S., Albus, C., Brotons, C., Catapano, A. L., Cooney, M.-T., Corrà, U., Cosyns, B., Deaton, C., Graham, I., Hall, M. S., Hobbs, F. D. R., Løchen, M.-L., Löllgen, H., Marques-Vidal, P., Perk, J., Prescott, E., Redon, J., Richter, D. J., Sattar, N., Smulders, Y., Tiberi, M., van der Worp, H. B., van Dis, I., Verschuren, W. M. M., Binno, S., ESC Scientific Document Group, De Backer, G., Roffi, M., Aboyans, V., Bachl, N., Bueno, H., Carerj, S., Cho, L., Cox, J., De Sutter, J., Egidi, G., Fisher, M., Fitzsimons, D., Franco, O. H., Guenoun, M., Jennings, C., Jug, B., Kirchhof, P., Kotseva, K., Lip, G. Y., Mach, F., Mancia, G., Bermudo, F. M., Mezzani, A., Niessner, A., Ponikowski, P., Rauch, B., Rydén, L., Stauder, A., Turc, G., Wiklund, O., Windecker, S., Zamorano, J. L., Zamorano, J. L., Aboyans, V., Achenbach, S., Agewall, S., Badimon, L., Barón-Esquivias, G., Baumgartner, H., Bax, J. J., Bueno, H., Carerj, S., Dean, V., Erol, Ç., Fitzsimons, D., Gaemperli, O., Kirchhof, P., Kolh, P., Lancellotti, P., Lip, G. Y., Nihoyannopoulos, P., Piepoli, M. F., Ponikowski, P., Roffi, M., Torbicki, A., Vaz Carneiro, A., Windecker, S., Metzler, B., Najafov, R., Stelmashok, V., De Maeyer, C., Dilic, M., Gruev, I., Milicic, D., Vaverkova, H., Gustafsson, I., Attia, I., Duishvili, D., Kostova, N., Ferrières, J., Klimiashvili, Z., Hambrecht, R., Tsioufis, K., Szabados, E., Andersen, K., Vaughan, C., Zafrir, B., Novo, S., Davletov, K., Jashari, F., Kerimkulova, A., Mintale, I., Saade, G., Petrulioniene, Z., Delagardelle, C., Magri, C. J., Rudi, V., Oukerraj, L., Çölkesen, B. E., Schirmer, H., Jankowski, P., dos Reis, R. P., Gherasim, D., Nedogoda, S., Zavatta, M., Giga, V., Filipova, S., Padial, L. R., Kiessling, A., Mach, F., Mahdhaoui, A., Ural, D., Nesukay, E., & Gale, C.
- Affiliations
- International Society of Behavioural Medicine (ISBM)
- World Organisation of Family Doctors (CN)
- European Atherosclerosis Society (SE)
- European Society of Cardiology (FR)
- International Diabetes Federation (BE)
- WONCA Europe.
- International Federation of Sports Medicine (CH)
- Societie: European Society of Hypertension (ESH)
- European Association for the Study of Diabetes (DE)
- Societie: European Stroke Organisation (ESO)
- Societie: European Heart Network (EHN)
- Societie: European Society of Cardiology (ESC)
- European Heart Network (BE)
- European Society of Hypertension (IT)
- European Stroke Organisation (CH)
- ORCID
- Hoes, Arno W
- Albus, Christian
- Brotons, Carlos
- Catapano, Alberico L
- Cooney, Marie-Therese
- Corrà, Ugo
- Cosyns, Bernard
- Deaton, Christi
- Graham, Ian
- Løchen, Maja-Lisa
- Löllgen, Herbert
- Marques-Vidal, Pedro
- Prescott, Eva
- Richter, Dimitrios J
- Sattar, Naveed
- Smulders, Yvo
- Tiberi, Monica
- Verschuren, W M Monique
- Franco, Oscar H
- Jug, Borut
- Turc, Guillaume
- Wiklund, Olov
- Bax, Jeroen J
- Erol, Çetin
- Kolh, Philippe
- Torbicki, Adam
- Najafov, Ruslan
- Gruev, Ivan
- Ferrières, Jean
- Zafrir, Barak
- Davletov, Kairat
- Kerimkulova, Alina
- Nedogoda, Sergey
- Giga, Vojislav
- Ural, Dilek
- Gale, Chris
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-05-23
- Volume
- 37
- Issue
- 29
- Pages
- 2315-2381
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- PMC
- PMC4986030
- OpenAlex
- W2402599050
- Cited by
- 6,457
- References
- 585
- Citations by year
- 2026: 178 · 2025: 279 · 2024: 398 · 2023: 509 · 2022: 678 · 2021: 996 · 2020: 1017 · 2019: 959 · 2018: 750 · 2017: 570 · 2016: 111
- FWCI
- 785.39
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- European Heart Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Pure Amsterdam UMC (publishedVersion, other-oa)
- Amsterdam UMC (VU Amsterdam) - Institutional Repository (publishedVersion)
- BOA (University of Milano-Bicocca) (submittedVersion)
- Utrecht University Repository (Utrecht University) (submittedVersion, other-oa)
- IRIS (submittedVersion)
- Nova Science Publishers (Nova Science Publishers, Inc.) (submittedVersion)
- HighWire Press Open Archive (submittedVersion)
- Open Repository and Bibliography (University of Liège) (submittedVersion, other-oa)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Data Archiving and Networked Services (DANS) (submittedVersion)
- Funders
- National Institute for Health and Care Research (NF-SI-0611-10273, 12/01/52)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Clinical practice guidelines implementation
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Keywords
- cardiovascular disease prevention, secondary prevention, primary prevention, cardiovascular risk management
- MeSH terms
- Healthy Lifestyle, Multiple Chronic Conditions, Diet, Healthy, Cardiac Rehabilitation, Adult, Age Factors, Aged, Antihypertensive Agents, Cardiovascular Diseases, Cost-Benefit Analysis, Diabetic Angiopathies, Diagnostic Imaging, Health Promotion, Humans, Hyperlipidemias, Hypertension, Middle Aged, Pedigree, Practice Patterns, Physicians', Sex Factors, Socioeconomic Factors, Biomarkers, Exercise, Smoking Cessation, Risk Assessment, General Practice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
